Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06007872

Intracardiac Echocardiography Guided Watchman Device Implant

This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location status: Recruiting

Location contact

Mohamed Kanj, MD

SUB_INVESTIGATOR

Oussama Wazni, MD

CONTACT

[email protected]

216-444-2131

Oussama Wazni, MD, MBA

PRINCIPAL_INVESTIGATOR

Rhonda Miyasaka, MD

SUB_INVESTIGATOR

Samir Kapadia, MD

SUB_INVESTIGATOR

Serge Harb, MD

SUB_INVESTIGATOR

Tyler Taigen, MD

SUB_INVESTIGATOR

Walid Saliba, MD

SUB_INVESTIGATOR

About this study

Left atrial appendage occlusion is approved as an indicated therapy for patients with non valvular atrial fibrillation, high risk of stroke and an appropriate rationale for avoidance of long term use of oral anticoagulants.

Concurrent procedural TEE is an integral part of the procedure. It is used to guide trans-septal puncture, device sizing and assessment of final adequacy of device implant.

TEE requires the participation and guidance of a cardiac imager and because the TEE probe is in place for a relatively long duration the procedure, the procedure is most commonly performed under general anesthesia. Furthermore TEE can be associated with risk of injury to the oropharynx and esophagus. Our ongoing clinical experience and known literature suggest that TEE may not be necessary for the overall success of the procedure. The objective of the study is to investigate a new work flow that may ultimately demonstrate that intra-procedural TEE may not be necessary, obviating the need for additional personnel, general anesthesia and decreasing overall risk. ICE has been widely used to aid trans-septal puncture and visualize left atrial anatomy. Smaller studies and case series have reported the use of ICE as an alternative to TEE in guiding Watchman device implant. This has not been compared systematically with TEE in a large patient sample.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients who meet guideline established criteria for commercially available Watchman device implant and not enrolled in an active clinical trial

Exclusion criteria

  • Patients in whom a procedural TEE cannot be performed and an ICE only implant is needed.
  • Patients receiving a concomitant ablation procedure
  • Patients with prior incomplete surgical or percutaneous left atrial appendage ligation/exclusion procedures
  • Patients in whom the delivery of trans-septal equipment is anticipated to be difficult (e.g. patent foramen ovale (PFO) or atrial septal defect (ASD) closure devices in place).

Treatment and study plan

Intracardiac Echocardiography (ICE)

Device

ICE will be used to guide trans-septal puncture and to guide device implant.

Primary outcomes

  1. Successful Watchman implantation using intracardiac echocardiography (ICE) guidance

    Time frame: During the procedure

    Intracardiac echocardiography (ICE) guided Watchman placement confirmed by transesophageal echocardiography (TEE)

Study contacts

Contact information is provided by the study sponsor or research team.

Oussama Wazni, MD

CONTACT

[email protected]

216-444-2131

Sponsors and collaborators

Lead sponsor

The Cleveland Clinic

Other

Registry information

Official study title

Feasibility: Intracardiac Echocardiography Guided Watchman Device Implant

Important dates

Study start
2022
Primary completion
2027
Study completion
2027
First posted
Aug 23, 2023
Registry last updated
Oct 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.